Issue 3 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

31

No.

3

March 28, 2008Mar 28, 2008

Free

DOWNLOAD THE PDF

Letrozole Cuts Risk Of Breast Cancer Recurrence Even After Tamoxifen Use

Recurrent Low-Grade Serous Carcinoma Less Responsive To Chemotherapy

BMI May Be Prognostic Tool For Types Of Breast Cancer

Postoperative Chemo Doesn’t Improve Survival, Study Finds

Risks Of Long-Term HRT Outweigh Benefits, WHI Finds

Cause Of Allergic Reaction To Cetuximab Found

NCI Cooperative Group, Cancer Center Trials Listed

Recent Issues

Volume 52 | Issue 24 - June 18, 2026

Volume 52 | Issue 23 - June 12, 2026

Volume 52 | Issue 22 - June 05, 2026

Volume 52 | Issue 21 - May 29, 2026

Volume 52 | Issue 20 - May 22, 2026

Volume 52 | Issue 19 - May 15, 2026